Wealthspire Advisors (Maryland)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $546K | Buy |
2,008
+941
| +88% | +$256K | 0.02% | 254 |
|
|
2020
Q2 | $310K | Buy |
1,067
+93
| +10% | +$27K | 0.02% | 333 |
|
|
2020
Q1 | $232K | Buy |
+974
| New | +$232K | 0.02% | 355 |
|
|
2019
Q2 | – | Sell |
-667
| Closed | -$123K | – | 2042 |
|
|
2019
Q1 | $123K | Sell |
667
-11
| -2% | -$2.03K | 0.01% | 570 |
|
|
2018
Q4 | $112K | Buy |
678
+79
| +13% | +$13.1K | 0.01% | 570 |
|
|
2018
Q3 | $115K | Buy |
599
+55
| +10% | +$10.6K | 0.01% | 631 |
|
|
2018
Q2 | $92K | Buy |
544
+40
| +8% | +$6.77K | 0.01% | 736 |
|
|
2018
Q1 | $82K | Sell |
504
-306
| -38% | -$49.8K | 0.01% | 788 |
|
|
2017
Q4 | $121K | Buy |
810
+159
| +24% | +$23.8K | 0.01% | 644 |
|
|
2017
Q3 | $99K | Buy |
651
+160
| +33% | +$24.3K | 0.01% | 715 |
|
|
2017
Q2 | $63K | Buy |
491
+251
| +105% | +$32.2K | 0.01% | 864 |
|
|
2017
Q1 | $26K | Buy |
240
+51
| +27% | +$5.53K | ﹤0.01% | 1000 |
|
|
2016
Q4 | $14K | Buy |
189
+53
| +39% | +$3.93K | ﹤0.01% | 1122 |
|
|
2016
Q3 | $12K | Sell |
136
-5
| -4% | -$441 | ﹤0.01% | 1208 |
|
|
2016
Q2 | $12K | Buy |
141
+37
| +36% | +$3.15K | ﹤0.01% | 1169 |
|
|
2016
Q1 | $8K | Buy |
104
+54
| +108% | +$4.15K | ﹤0.01% | 1239 |
|
|
2015
Q4 | $6K | Buy |
+50
| New | +$6K | ﹤0.01% | 1322 |
|